Skip to main content

Drugs: Innovation

Question for Department of Health

UIN 116833, tabled on 30 November 2017

To ask the Secretary of State for Health, what steps he is taking to encourage greater collaboration between investment in life sciences and innovative medicines in the NHS.

Answered on

5 December 2017

The Life Sciences Industrial Strategy (LSIS) set out the ambition to make the United Kingdom a global hub for clinical research and medical innovation. The Government welcomed the ambition of the LSIS, and is working in partnership with industry to deliver this through the upcoming Sector Deal.

Our commitment to making a reality of the Accelerated Access Review was also set out in our publication on 3 November. Here, we committed to improving collaboration between the National Health Service and industry, and to improve the access and uptake of innovative medicines and treatments, including the ambition to accelerate patient access by up to four years.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.